Pain block showdown for heart surgery patients ends early
NCT ID NCT04868058
First seen Dec 24, 2025 · Last updated Jun 22, 2026 · Updated 23 times
Summary
This study compared two types of nerve blocks (serratus anterior plane block and erector spinae plane block) using the same dose of ropivacaine to manage pain after hybrid arrhythmia ablation surgery. It enrolled 28 adults aged 18-80. The trial was terminated early, so findings are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Universitair Ziekenhuis
Brussels, Brussels Capital, 1090, Belgium
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ropivacaine (Naropin) injection
What this could lead to
If successful, this could show which nerve block works better for pain after heart rhythm surgery.
What could go wrong
The study was terminated early, so results are limited. It was small (28 people) and only tested pain control, not a cure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.